Literature DB >> 29660141

Carbonic anhydrase is not a relevant nitrite reductase or nitrous anhydrase in the lung.

Philipp A Pickerodt1, Sebastian Kronfeldt1, Martin Russ1, Adrian Gonzalez-Lopez1, Philipp Lother1, Elvira Steiner1, Katja Vorbrodt1, Thilo Busch2, Willehad Boemke1, Roland C E Francis1, Erik R Swenson3,4.   

Abstract

KEY POINTS: Carbonic anhydrase (CA) inhibitors such as acetazolamide inhibit hypoxic pulmonary vasoconstriction (HPV) in humans and other mammals, but the mechanism of this action remains unknown. It has been postulated that carbonic anhydrase may act as a nitrous anhydrase in vivo to generate nitric oxide (NO) from nitrite and that this formation is increased in the presence of acetazolamide. Acetazolamide reduces HPV in pigs without evidence of any NO generation, whereas nebulized sodium nitrite reduces HPV by NO formation; however; combined infusion of acetazolamide with sodium nitrite inhalation did not further increase exhaled NO concentration over inhaled nitrite alone in pigs exposed to alveolar hypoxia. We conclude that acetazolamide does not function as either a nitrous anhydrase or a nitrite reductase in the lungs of pigs, and probably other mammals, to explain its vasodilating actions in the pulmonary or systemic circulations. ABSTRACT: The carbonic anhydrase (CA) inhibitors acetazolamide and its structurally similar analogue methazolamide prevent or reduce hypoxic pulmonary vasoconstriction (HPV) in dogs and humans in vivo, by a mechanism unrelated to CA inhibition. In rodent blood and isolated blood vessels, it has been reported that inhibition of CA leads to increased generation of nitric oxide (NO) from nitrite and vascular relaxation in vitro. We tested the physiological relevance of augmented NO generation by CA from nitrite with acetazolamide in anaesthetized pigs during alveolar hypoxia in vivo. We found that acetazolamide prevents HPV in anaesthetized pigs, as in other mammalian species. A single nebulization of sodium nitrite reduces HPV, but this action wanes in the succeeding 3 h of hypoxia as nitrite is metabolized and excreted. Pulmonary artery pressure reduction and NO formation as measured by exhaled gas concentration from inhaled sodium nitrite were not increased by acetazolamide during alveolar hypoxia. Thus, our data argue against a physiological role of carbonic anhydrase as a nitrous anhydrase or nitrite reductase as a mechanism for its inhibition of HPV in the lung and blood in vivo.
© 2018 The Authors. The Journal of Physiology © 2018 The Physiological Society.

Entities:  

Keywords:  acetazolamide; carbonic anhydrase; hypoxia; hypoxic pulmonary vasoconstriction; nitrite; pig

Year:  2018        PMID: 29660141      PMCID: PMC6376076          DOI: 10.1113/JP275894

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  5 in total

1.  Overview: pulmonary vascular function in health and disease.

Authors:  Larissa A Shimoda
Journal:  J Physiol       Date:  2019-02       Impact factor: 5.182

Review 2.  Role of Nitric Oxide Carried by Hemoglobin in Cardiovascular Physiology: Developments on a Three-Gas Respiratory Cycle.

Authors:  Richard T Premont; James D Reynolds; Rongli Zhang; Jonathan S Stamler
Journal:  Circ Res       Date:  2019-10-08       Impact factor: 17.367

3.  Carbonic anhydrase II does not regulate nitrite-dependent nitric oxide formation and vasodilation.

Authors:  Ling Wang; Courtney E Sparacino-Watkins; Jun Wang; Nadeem Wajih; Paul Varano; Qinzi Xu; Eric Cecco; Jesús Tejero; Manoocher Soleimani; Daniel B Kim-Shapiro; Mark T Gladwin
Journal:  Br J Pharmacol       Date:  2019-12-23       Impact factor: 8.739

4.  Nitrous anhydrase activity of carbonic anhydrase II: cysteine is required for nitric oxide (NO) dependent phosphorylation of VASP in human platelets.

Authors:  Dimitrios Tsikas; Stepan Gambaryan
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

5.  Acetazolamide for OSA and Central Sleep Apnea: A Comprehensive Systematic Review and Meta-Analysis.

Authors:  Christopher N Schmickl; Shane A Landry; Jeremy E Orr; Kazuo Chin; Kimihiko Murase; Johan Verbraecken; Shahrokh Javaheri; Bradley A Edwards; Robert L Owens; Atul Malhotra
Journal:  Chest       Date:  2020-08-05       Impact factor: 9.410

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.